Jan Medical has enrolled its first patient in a clinical study of the company’s portable, continuous brain-sensing system to detect cerebral vasospasm.
The study, to be conducted at the University of California, San Francisco, US, is designed to evaluate the Nautilus NeuroWave system’s ability to detect vasospasms.
Approximately 70 patients who have survived a subarachnoid haemorrhage stroke will be enrolled in the study.
Jan Medical CEO Paul Lovoi said the Nautilus NeuroWave system can provide critical information on a patient presenting with stroke symptoms, and can also be used as a continuous monitor of changes to the cerebral vasculature.
“We are hopeful that this study will confirm our portable and continuous brain-sensing system’s ability to detect vasospasms quickly and noninvasively,” Lovoi said.
